Latanoprost and Vomiting aggravated - a phase IV clinical study of FDA data

Summary:

Vomiting aggravated is reported as a side effect among people who take Latanoprost (latanoprost), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Amlodipine, and have Pain.

The phase IV clinical study analyzes which people have Vomiting aggravated when taking Latanoprost. It is created by eHealthMe based on reports of 32,842 people who have side effects when taking Latanoprost from the FDA, and is updated regularly.

What is Latanoprost?

Latanoprost has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 33,250 Latanoprost users. Check the latest studies of Latanoprost.

What is Vomiting aggravated?

Vomiting aggravated is found to be associated with 1,951 drugs and 733 conditions by eHealthMe. Check the latest studies of Vomiting aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

32,842 people reported to have side effects when taking Latanoprost.
Among them, 491 people (1.5%) have Vomiting aggravated.

Could Latanoprost cause Vomiting aggravated?

Among these 491 people:

How long have people been on Latanoprost when they have Vomiting aggravated? *

Click here to view more results

What is the gender of people who have Vomiting aggravated when taking Latanoprost? *

Click here to view

What is the age of people who have Vomiting aggravated when taking Latanoprost? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Latanoprost and have Vomiting aggravated?

- Check whether Vomiting aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Latanoprost:

Latanoprost (33,250 reports)

Vomiting aggravated treatments and more:

Vomiting aggravated (33 reports)

How severe was Vomiting aggravated and when was it recovered:

Vomiting aggravated in Latanoprost

Expand to all the drugs that have ingredients of latanoprost:

Vomiting aggravated and drugs with ingredients of latanoprost

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Latanoprost:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vomiting aggravated:

Vomiting aggravated (1,951 drugs)

Browse all the conditions that are associated with Vomiting aggravated:

Vomiting aggravated (733 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on latanoprost (the active ingredients of Latanoprost) and Latanoprost (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.